Dark

PCSA
Processa Pharmaceuticals, Inc. Common
stock NASDAQ

At Close

Jan 23, 2026 3:58:30 PM EST

3.29USD+3.785%(+0.12)90,680

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 22, 2026 8:25:30 AM EST

3.13USD-1.262%(-0.04)0

After-hours

Jan 21, 2026 4:37:30 PM EST

3.13USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

7.50M

Industry

Biotechnology

Next Earnings

Mar 19, 2026 (52d)

Last Split

Dec 17, 20251for25reverse

PCSA Stats

Avg. Vol. 10 Day

94,687

Avg. Vol. 30 Day

1,581,677

Employees

Market Cap

7,499,692

Shares Out.

2,265,768

On/Off Exchange

45%/55%

6 Month Beta

0.27

1 Year Beta

0.33

2 Year Beta

0.46

3 Year Beta

0.60

52 Week Low

2.74

52 Week High

20.22

SMA50

5.08

SMA200

6.03

1 Week

+2.16%

1 Month

-15.56%

3 Month

-57.32%

6 Month

-45.47%

1 Year

-80.59%

2 Year

-97.40%

5 Year

-99.90%

Profile

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

PCSA Stock Summary

Processa Pharmaceuticals, Inc. Common (NASDAQ:PCSA) stock price today is $3.29, and today's volume is 90,680. PCSA is up 3.785% today. The 30 day average volume is 1,581,677. PCSA market cap is 7.50M with 2,265,768 shares outstanding.

.dark-mode .b3GgSz{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .b3GgSz{ color: #333333; background-color: white; border: 2px solid #333333; }PCSAProcessa Pharmaceuticals, Inc. Commonstock NASDAQ

PCSA Stock Summary

PCSA
Processa Pharmaceuticals, Inc. Common
stock NASDAQ